Work Description

Title: Literature search files for review on lifestyle therapy for the management of atrial fibrillation Open Access Deposited

http://creativecommons.org/licenses/by-nc/4.0/
Attribute Value
Methodology
  • Comprehensive searches were run in Ovid MEDLINE, Embase.com, and CINAHL (EBSCOhost). The search strategies were documented, as were the complete result sets from all searches. The resulting citations were moved to the citation manager Endnote X6 (Clarivate Analytics). Duplicates were removed in the program and results were exported to Excel (Microsoft).
Description
  • The search data supports a literature review project on lifestyle therapies for the management of atrial fibrillation. The data included in the dataset are the reproducible search strategies (in docx) and the exported results of all citations from all databases (txt and ris files). These searches and exported result files contain all citations originating from the database searches that were considered for inclusion.
Creator
Depositor
  • markmac@umich.edu
Contact information
Discipline
Keyword
Citations to related material
Resource type
Last modified
  • 04/27/2020
Published
  • 03/20/2019
Language
DOI
  • https://doi.org/10.7302/7wan-sx10
License
To Cite this Work:
MacEachern, M. (2019). Literature search files for review on lifestyle therapy for the management of atrial fibrillation [Data set]. University of Michigan - Deep Blue. https://doi.org/10.7302/7wan-sx10

Relationships

Files (Count: 7; Size: 6.46 MB)

PMID- 26919833
OWN - NLM
STAT- Publisher
DA - 20160227
LR - 20160228
IS - 1672-0415 (Electronic)
IS - 1672-0415 (Linking)
DP - 2016 Feb 26
TI - Comparison of aspirin and Naoxintong Capsule () with adjusted-dose warfarin in
elderly patients with high-risk of non-valvular atrial fibrillation and genetic
variants of vitamin K epoxide reductase.
AB - OBJECTIVE: To compared the therapeutic effect of a Chinese patent medicine
Naoxintong Capsule (, NXT) and aspirin with adjusted-dose warfarin in Chinese
elderly patients (over 65 years) with nonvalvular atrial fibrillation (NVAF) and
genetic variants of vitamin K epoxide reductase (VKORC1), who are at high-risk of
thromboembolism. METHODS: A total of 151 patients, with NVAF and AA genotype of
VKORC1-1639 (a sensitive genotype to warfarin) and a CHA2DS2-VASc clinical risk
score of 2 or above, were chosen for this study. Patients were randomized into
two groups and orally treated with a combination of aspirin (100 mg/day) and NXT
(1.6 g thrice a day) or adjusted-dose warfarin [international normalized ratio
2.0-3.0). The primary end points including ischemic stroke and death as well as
the secondary end points including hemorrhage events were followed up for at
least 1 year. RESULTS: Baseline clinical data and the rates of primary end points
were similar between groups. However, the rate of serious bleeding (secondary
event) in the combination therapy group was lower than that in the adjusted-dose
warfarin group (0% vs. 7.9%, odds ratio: 0.921, 95% confidence interval:
0.862-0.984, P=0.028). CONCLUSIONS: Aspirin combined with NXT and warfarin
displayed comparable rates of primary end point including ischemic stroke and
all-cause death during the 1-year follow-up. However, as compared with warfarin,
the combination therapy reduced the rate of serious bleeding. Therefore, aspirin
combined with NXT might provide an alternative pharmacotherapy in preventing
ischemic stroke for elderly patients with NAVF who cannot tolerate warfarin. (No.
ChiCTR-TRC-13003596).
FAU - Wang, Huan
AU - Wang H
AD - Department of Internal Medicine, Fujian Provincial Cardiovascular Disease
Institute, Provincial Clinical College of Fujian Medical University, Fuzhou,
350001, China.
FAU - Zhou, Xiao-Kai
AU - Zhou XK
AD - Cardiovascular Internal Medicine, Quzhou People's Hospital of Zhejiang Province,
Quzhou, Zhejiang Province, 324000, China.
FAU - Zheng, Li-Fan
AU - Zheng LF
AD - Cardiovascular Internal Medicine, the Affiliated Hospital in Putian College of
Fujian Province, Putian, Fujian Province, 351100, China.
FAU - Wu, Xiao-Ying
AU - Wu XY
AD - Department of Internal Medicine, Fujian Provincial Cardiovascular Disease
Institute, Provincial Clinical College of Fujian Medical University, Fuzhou,
350001, China.
FAU - Chen, Hui
AU - Chen H
AD - Department of Internal Medicine, Fujian Provincial Cardiovascular Disease
Institute, Provincial Clinical College of Fujian Medical University, Fuzhou,
350001, China. chenhuiwyd@sina.com.
LA - ENG
PT - JOURNAL ARTICLE
DEP - 20160226
TA - Chin J Integr Med
JT - Chinese journal of integrative medicine
JID - 101181180
OTO - NOTNLM
OT - Chinese medicine
OT - alternative medicine
OT - antithrombotic therapy
OT - aspirin combined with Naoxintong
OT - atrial fibrillation
OT - genetic variants
OT - warfarin
EDAT- 2016/02/28 06:00
MHDA- 2016/02/28 06:00
CRDT- 2016/02/28 06:00
PHST- 2015/03/18 [received]
PHST- 2016/02/26 [aheadofprint]
AID - 10.1007/s11655-015-2443-4 [doi]
AID - 10.1007/s11655-015-2443-4 [pii]
PST - aheadofprint
SO - Chin J Integr Med. 2016 Feb 26.

PMID- 26074982
OWN - NLM
STAT- PubMed-not-MEDLINE
DA - 20150615
DCOM- 20150615
LR - 20150617
IS - 1741-427X (Print)
IS - 1741-427X (Linking)
VI - 2015
DP - 2015
TI - Wenxin Keli versus Sotalol for Paroxysmal Atrial Fibrillation Caused by
Hyperthyroidism: A Prospective, Open Label, and Randomized Study.
PG - 101904
LID - 10.1155/2015/101904 [doi]
AB - We aimed to compare effectiveness of Wenxin Keli (WK) and sotalol in assisting
sinus rhythm (SR) restoration from paroxysmal atrial fibrillation (PAF) caused by
hyperthyroidism, as well as in maintaining SR. We randomly prescribed WK (18 g
tid) or sotalol (80 mg bid) to 91 or 89 patients. Since it was not ethical not to
give patients antiarrhythmia drugs, no control group was set. Antithyroid drugs
were given to 90 patients (45 in WK group, 45 in sotalol group); (131)I was given
to 90 patients (46 in WK group, 44 in sotalol group). Three months later, SR was
obtained in 83/91 or 80/89 cases from WK or sotalol groups (P = 0.762). By
another analysis, SR was obtained in 86/90 or 77/90 cases from (131)I or ATD
groups (P = 0.022). Then, we randomly assigned the successfully SR-reverted
patients into three groups: WK, sotalol, and control (no antiarrhythmia drug was
given) groups. After twelve-month follow-up, PAF recurrence happened in 1/54,
2/54, and 9/55 cases, respectively. Log-Rank test showed significant higher PAF
recurrent rate in control patients than either treatment (P = 0.06). We
demonstrated the same efficacies of WK and sotalol to assist SR reversion from
hyperthyroidism-caused PAF. We also showed that either drug could maintain SR in
such patients.
FAU - Meng, Zhaowei
AU - Meng Z
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Tan, Jian
AU - Tan J
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - He, Qing
AU - He Q
AD - Department of Endocrinology, Tianjin Medical University General Hospital, Tianjin
300052, China.
FAU - Zhu, Mei
AU - Zhu M
AD - Department of Endocrinology, Tianjin Medical University General Hospital, Tianjin
300052, China.
FAU - Li, Xue
AU - Li X
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Zhang, Jianping
AU - Zhang J
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Jia, Qiang
AU - Jia Q
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Wang, Shen
AU - Wang S
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Zhang, Guizhi
AU - Zhang G
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
FAU - Zheng, Wei
AU - Zheng W
AD - Department of Nuclear Medicine, Tianjin Medical University General Hospital,
Anshan Road No. 154, Heping District, Tianjin 300052, China.
LA - eng
PT - Journal Article
DEP - 20150517
PL - United States
TA - Evid Based Complement Alternat Med
JT - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC4449914
OID - NLM: PMC4449914
EDAT- 2015/06/16 06:00
MHDA- 2015/06/16 06:01
CRDT- 2015/06/16 06:00
PHST- 2014/06/27 [received]
PHST- 2014/10/05 [revised]
PHST- 2014/10/12 [accepted]
PHST- 2015/05/17 [epublish]
AID - 10.1155/2015/101904 [doi]
PST - ppublish
SO - Evid Based Complement Alternat Med. 2015;2015:101904. doi: 10.1155/2015/101904.
Epub 2015 May 17.

PMID- 25784948
OWN - NLM
STAT- PubMed-not-MEDLINE
DA - 20150318
DCOM- 20150318
LR - 20150321
IS - 1741-427X (Print)
IS - 1741-427X (Linking)
VI - 2015
DP - 2015
TI - Acupuncture antiarrhythmic effects on drug refractory persistent atrial
fibrillation: study protocol for a randomized, controlled trial.
PG - 613970
LID - 10.1155/2015/613970 [doi]
AB - Background. Atrial fibrillation (AF) is the most common form of arrhythmia.
Several trials have suggested that acupuncture may prevent AF. However, the
efficacy of acupuncture for AF prevention has not been well investigated.
Therefore, we designed a prospective, two-parallel-armed, participant and
assessor blinded, randomized, sham-controlled clinical trial to investigate
acupuncture in persistent AF (ACU-AF). Methods. A total of 80 participants will
be randomly assigned to active acupuncture or sham acupuncture groups in a 1 : 1
ratio. Both groups will take the same antiarrhythmic medication during the study
period. Patients will receive 10 sessions of acupuncture treatment once a week
for 10 weeks. The primary endpoint is AF recurrence rate. Secondary endpoints are
left atrium (LA) and left atrial appendage (LAA) changes in function and volume,
and inflammatory biomarker changes. Ethics. This study protocol was approved by
the institutional review boards (IRBs) of Kyung Hee University Hospital (number
1335-04). This trial is registered with clinicaltrials.gov NCT02110537.
FAU - Park, Jimin
AU - Park J
AD - Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee
University, Seoul 130-701, Republic of Korea.
FAU - Kim, Hyun Soo
AU - Kim HS
AD - Division of Cardiology, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul 130-701, Republic of Korea.
FAU - Lee, Seung Min
AU - Lee SM
AD - Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee
University, Seoul 130-701, Republic of Korea.
FAU - Yoon, Kanghyun
AU - Yoon K
AD - Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee
University, Seoul 130-701, Republic of Korea.
FAU - Kim, Woo-Shik
AU - Kim WS
AD - Division of Cardiology, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul 130-701, Republic of Korea.
FAU - Woo, Jong Shin
AU - Woo JS
AD - Division of Cardiology, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul 130-701, Republic of Korea.
FAU - Lee, Sanghoon
AU - Lee S
AD - Department of Acupuncture and Moxibustion, College of Korean Medicine, Kyung Hee
University, Seoul 130-701, Republic of Korea.
FAU - Kim, Jin-Bae
AU - Kim JB
AD - Division of Cardiology, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul 130-701, Republic of Korea.
FAU - Kim, Weon
AU - Kim W
AD - Division of Cardiology, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul 130-701, Republic of Korea.
LA - eng
PT - Journal Article
DEP - 20150217
PL - United States
TA - Evid Based Complement Alternat Med
JT - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC4346697
OID - NLM: PMC4346697
EDAT- 2015/03/19 06:00
MHDA- 2015/03/19 06:01
CRDT- 2015/03/19 06:00
PHST- 2014/11/11 [received]
PHST- 2015/01/16 [revised]
PHST- 2015/01/31 [accepted]
PHST- 2015/02/17 [epublish]
AID - 10.1155/2015/613970 [doi]
PST - ppublish
SO - Evid Based Complement Alternat Med. 2015;2015:613970. doi: 10.1155/2015/613970.
Epub 2015 Feb 17.

PMID- 26934795
OWN - NLM
STAT- MEDLINE
DA - 20160303
DCOM- 20160324
IS - 0360-1293 (Print)
IS - 0360-1293 (Linking)
VI - 40
IP - 4
DP - 2015
TI - Using new non-invasive quick method to detect Borrelia Burgdorferi (B.B.)
infection from specific parts of the heart in "seemingly normal" ECGs, and from
the ECGs of Atrial Fibrillation (AF), a majority of AF ECGs are found to have: 1)
Significant B.B. infection, 2) Markedly increased ANP, 3) Increased Cardiac
Troponin I & 4) Markedly reduced Taurine. These 4 factors were mainly localized
at infected areas of the SA node area, R-&L-Atria & pulmonary veins at the
L-atrium.
PG - 297-333
AB - Lyme disease is found in a majority of people we tested. Once Borrelia
Burgdorferi (B.B.) spirochete enters human body, it not only causes pain by
infecting joints, but it also often enters the brain and the heart. Infection of
brain can be quickly detected from the pupil and infection of the heart by ECGs
non-invasively. By evaluating recorded ECGs of atrial fibrillation (AF), using
U.S. patented non-invasive highly sensitive electromagnetic field (EMF) resonance
phenomenon between 2 identical molecules or between a molecule and its antibody,
we examined 25 different AF patients' ECGs and found the majority of them suffer
from various degrees of B.B. spirochete infection in SA node areas, also in the
right & left atria, and pulmonary vein near and around its junction at left
atrium & lesser degrees of infection at the AV node & His Bundle. When B.B.
infection reaches over 224-600ng or higher at these areas, AF often appears in
the majority of all AF analyzed. In order to develop AF, the 4 abnormal factors
must be present simultaneously: 1) B.B. infection must be increased to 224-600ng
or higher, 2) Atrial Natriuretic Peptide (ANP) must be markedly reduced from
normal value of less than 4ng to over 100-400ng, 3) A significant increase of
Cardiac Troponin I from normal value of less than 3ng to over 12ng and 4) Taurine
must also be markedly reduced from normal value of 4-6ng to 0.25ng. These 4
changes were mainly found only at infected sites of the SA node area, both atria
and between the end of the T wave & the beginning of the SA node area, which
corresponds to U waves at recorded ECG. Origin of the U wave is mainly due to
abnormal electrical potential of pulmonary vein at L-atrium. If all 4 factors do
not occur at the infection site, no AF will develop. In seemingly normal ECGs, if
using this method, one can detect invisible B.B. infection in early stages. Long
before AF appears, AF can be prevented by improved treatment with Amoxicillin
500ng 3 times/day + Taurine 175mg x 3 times/day, with or without EPA 180 mg & DHA
120 mg, to avoid serious current limitations in the use of Doxycycline 100 mg 2
times/day, for 4 weeks.
FAU - Omura, Yoshiaki
AU - Omura Y
FAU - Lu, Dominic
AU - Lu D
FAU - Jones, Marilyn K
AU - Jones MK
FAU - Nihrane, Abdallah
AU - Nihrane A
FAU - Duvvi, Harsha
AU - Duvvi H
FAU - Yapor, Dario
AU - Yapor D
FAU - Shimotsuura, Yasuhiro
AU - Shimotsuura Y
FAU - Ohki, Motomu
AU - Ohki M
LA - eng
PT - Journal Article
PL - United States
TA - Acupunct Electrother Res
JT - Acupuncture & electro-therapeutics research
JID - 7610364
RN - 0 (Troponin I)
RN - 1EQV5MLY3D (Taurine)
RN - 85637-73-6 (Atrial Natriuretic Factor)
SB - IM
MH - Atrial Fibrillation/diagnosis/genetics/*metabolism/*microbiology
MH - Atrial Natriuretic Factor/*metabolism
MH - Borrelia burgdorferi/genetics/*isolation & purification
MH - Electrocardiography
MH - Heart Atria/*metabolism
MH - Humans
MH - Lyme Disease/microbiology
MH - Pulmonary Veins/*metabolism
MH - Sinoatrial Node/*metabolism
MH - Taurine/metabolism
MH - Troponin I/*metabolism
EDAT- 2015/01/01 00:00
MHDA- 2016/03/25 06:00
CRDT- 2016/03/04 06:00
PST - ppublish
SO - Acupunct Electrother Res. 2015;40(4):297-333.

PMID- 24368925
OWN - NLM
STAT- PubMed-not-MEDLINE
DA - 20131225
DCOM- 20140624
LR - 20140624
IS - 1741-427X (Print)
IS - 1741-427X (Linking)
VI - 2013
DP - 2013
TI - The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm
in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized
controlled trials.
PG - 245958
LID - 10.1155/2013/245958 [doi]
AB - Objective. To evaluate the beneficial and adverse effects of Wenxin Keli (WXKL),
alone or combined with Western medicine, on P-wave dispersion (Pd) and
maintenance of sinus rhythm for the treatment of paroxysmal atrial fibrillation
(PAF). Methods. Seven major electronic databases were searched to retrieve
randomized controlled trials (RCTs) designed to evaluate the clinical
effectiveness of WXKL, alone or combined with Western medicine, for PAF, with Pd
or maintenance rate of sinus rhythm as the main outcome measure. The
methodological quality of the included studies was assessed using criteria from
the Cochrane Handbook for Systematic Review of Interventions, version 5.1.0, and
analysed using RevMan 5.1.0 software. Results. Fourteen RCTs of WXKL were
included. The methodological quality of the trials was generally evaluated as
low. The results of meta-analysis showed that WXKL, alone or combined with
Western medicine, was more effective in Pd and the maintenance of sinus rhythm,
compared with no medicine or Western medicine alone, in patients with PAF or PAF
complicated by other diseases. Seven of the trials reported adverse events,
indicating that the safety of WXKL is still uncertain. Conclusions. WXKL, alone
or combined with Western medicine, appears to be more effective in improving Pd
as well as maintenance of sinus rhythm in patients with PAF and its
complications.
FAU - Chen, Yu
AU - Chen Y
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China ; Shenyang Pharmaceutical University, Shenyang, Liaoning 110016,
China.
FAU - Nie, Shaoping
AU - Nie S
AD - Beijing An Zhen Hospital of the Capital University of Medical Sciences, Beijing
100029, China.
FAU - Gao, Hai
AU - Gao H
AD - Beijing An Zhen Hospital of the Capital University of Medical Sciences, Beijing
100029, China.
FAU - Sun, Tao
AU - Sun T
AD - Beijing An Zhen Hospital of the Capital University of Medical Sciences, Beijing
100029, China.
FAU - Liu, Xiaoqiu
AU - Liu X
AD - Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, China.
FAU - Teng, Fei
AU - Teng F
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China.
FAU - Xing, Yanhui
AU - Xing Y
AD - Institute of Information on Traditional Chinese Medicine, Academy of Chinese
Medical Sciences, Beijing 100700, China.
FAU - Chen, Wen
AU - Chen W
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China.
FAU - Zhang, Zhenpeng
AU - Zhang Z
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China.
FAU - Gao, Yonghong
AU - Gao Y
AD - The Key Laboratory of Chinese Internal Medicine of the Ministry of Education,
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing
100700, China.
FAU - Wang, Jie
AU - Wang J
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China.
FAU - Xing, Yanwei
AU - Xing Y
AD - Guang'anmen Hospital, Chinese Academy of Chinese Medical Sciences, Beijing
100053, China.
FAU - Shang, Hongcai
AU - Shang H
AD - Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
LA - eng
PT - Journal Article
PT - Review
DEP - 20131204
PL - United States
TA - Evid Based Complement Alternat Med
JT - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC3867920
OID - NLM: PMC3867920
EDAT- 2013/12/26 06:00
MHDA- 2013/12/26 06:01
CRDT- 2013/12/26 06:00
PHST- 2013/07/18 [received]
PHST- 2013/10/15 [accepted]
PHST- 2013/12/04 [epublish]
AID - 10.1155/2013/245958 [doi]
PST - ppublish
SO - Evid Based Complement Alternat Med. 2013;2013:245958. doi: 10.1155/2013/245958.
Epub 2013 Dec 4.

PMID- 24273987
OWN - NLM
STAT- MEDLINE
DA - 20131126
DCOM- 20150105
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 33
IP - 9
DP - 2013 Sep
TI - [Yoga and atrial fibrillation: inspiration from studies on yoga my heart].
PG - 1267-8
FAU - Liu, Yue
AU - Liu Y
FAU - Chen, Ke-Ji
AU - Chen KJ
LA - chi
PT - Journal Article
PL - China
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
SB - IM
MH - *Atrial Fibrillation
MH - Humans
MH - Prospective Studies
MH - *Yoga
EDAT- 2013/11/28 06:00
MHDA- 2015/01/06 06:00
CRDT- 2013/11/27 06:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Sep;33(9):1267-8.

PMID- 24195206
OWN - NLM
STAT- MEDLINE
DA - 20131107
DCOM- 20140102
IS - 0255-2930 (Print)
IS - 0255-2930 (Linking)
VI - 33
IP - 8
DP - 2013 Aug
TI - [Clinical efficacy observation on paroxysmal atrial fibrillation treated by
acupuncture combined with Wenxin granule].
PG - 686-8
AB - OBJECTIVE: To compare the difference of clinical efficacy in the treatment of
paroxysmal atrial fibrillation (PAF) between acupuncture combined with Wenzin
granule and simple Wenxin granule therapy. METHODS: Sixty hospitalized cases of
PAF were randomized into a medication group and a medication--acupuncture group.
Wenxin granule was given to the patients in the two groups 3 times a day, 9 g
each time, 4 weeks as a treatment course. Meanwhile, acupuncture was added to the
medication--acupuncture group at bilateral Neiguan (PC 6), Shenmen (HT 7), Ximen
(PC 4) with uneven reinforcing-reducing manipulation every 15 min, 1 min each
time. The needle was retained for 30 minutes. The acupuncture was given once
daily for continuously 4 weeks. The therapeutic efficacy of the two groups was
assessed after treatment. METHODS: In the medication+acupuncture group, 18 cases
were markedly effective, 10 cases were effective and 2 cases were failed, the
total effective rate was 93.3%; in the medication group, 15 cases were markedly
effective, 8 cases were effective and 7 cases were failed, the total effective
rate was 76.7%. There were statistical significances in clinical efficacy between
the two groups (P<0.05). CONCLUSION: Acupuncture combined with Wenxin granule has
a better effect than simple Wenxin granule therapy in the treatment of paroxysmal
atrial fibrillation.
FAU - Zhang, Xue-Lian
AU - Zhang XL
AD - Department of Physiotherapy, Second People's Hospital of Hengshui, Hengshui
053000, Hebei Province, China. maryhb@163.com
FAU - Lou, Man
AU - Lou M
FAU - Wang, Hong-Ye
AU - Wang HY
LA - chi
PT - English Abstract
PT - Journal Article
PT - Randomized Controlled Trial
PT - Research Support, Non-U.S. Gov't
PL - China
TA - Zhongguo Zhen Jiu
JT - Zhongguo zhen jiu = Chinese acupuncture & moxibustion
JID - 8600658
RN - 0 (Drugs, Chinese Herbal)
SB - IM
MH - *Acupuncture Therapy
MH - Adult
MH - Aged
MH - Atrial Fibrillation/drug therapy/*therapy
MH - Combined Modality Therapy
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Female
MH - Humans
MH - Male
MH - Middle Aged
MH - Treatment Outcome
EDAT- 2013/11/08 06:00
MHDA- 2014/01/03 06:00
CRDT- 2013/11/08 06:00
PST - ppublish
SO - Zhongguo Zhen Jiu. 2013 Aug;33(8):686-8.

PMID- 23884291
OWN - NLM
STAT- MEDLINE
DA - 20130902
DCOM- 20140421
LR - 20150423
IS - 1759-9873 (Electronic)
IS - 0964-5284 (Linking)
VI - 31
IP - 3
DP - 2013 Sep
TI - Integrated approach to treatment-resistant atrial fibrillation: additional value
of acupuncture.
PG - 327-30
LID - 10.1136/acupmed-2013-010380 [doi]
AB - A 62-year-old patient with chronic bronchitis had treatment-resistant atrial
fibrillation. Electrical cardioversion was performed, but sinus rhythm (SR)
lasted only for some minutes. Administration of amiodarone was withheld in favour
of a course of acupuncture treatment in order to increase the success rate of a
second attempt of electrical cardioversion. After two acupuncture treatments,
spontaneous conversion to SR occurred. Relapses into atrial fibrillation in the
following five winters, associated with attacks of bronchitis, also responded to
acupuncture. The mechanisms of action of the acupuncture treatment and the value
of this integrated approach to treatment are discussed.
FAU - Jonkman, F A M
AU - Jonkman FA
AD - Department of Acupuncture, Acupuncture Outpatient Clinic Heel de Mens, Heelsum,
The Netherlands. info@humanbalance.nl
FAU - Jonkman-Buidin, M L
AU - Jonkman-Buidin ML
LA - eng
PT - Case Reports
PT - Journal Article
DEP - 20130724
PL - England
TA - Acupunct Med
JT - Acupuncture in medicine : journal of the British Medical Acupuncture Society
JID - 9304117
SB - IM
MH - *Acupuncture Therapy
MH - Atrial Fibrillation/physiopathology/*therapy
MH - *Electric Countershock
MH - Humans
MH - Male
MH - Middle Aged
PMC - PMC3786618
OID - NLM: PMC3786618
OTO - NOTNLM
OT - ACUPUNCTURE
OT - CARDIOLOGY
OT - CLINICAL PHARMACOLOGY
OT - COMPLEMENTARY MEDICINE
EDAT- 2013/07/26 06:00
MHDA- 2014/04/22 06:00
CRDT- 2013/07/26 06:00
PHST- 2013/07/24 [aheadofprint]
AID - acupmed-2013-010380 [pii]
AID - 10.1136/acupmed-2013-010380 [doi]
PST - ppublish
SO - Acupunct Med. 2013 Sep;31(3):327-30. doi: 10.1136/acupmed-2013-010380. Epub 2013
Jul 24.

PMID- 24176784
OWN - NLM
STAT- MEDLINE
DA - 20131101
DCOM- 20160423
IS - 1531-2054 (Print)
IS - 1531-2054 (Linking)
VI - 23 Suppl
DP - 2013
TI - 2013 SYR Accepted Poster Abstracts.
PG - 32-53
AB - SYR 2013 Accepted Poster abstracts: 1. Benefits of Yoga as a Wellness Practice in
a Veterans Affairs (VA) Health Care Setting: If You Build It, Will They Come? 2.
Yoga-based Psychotherapy Group With Urban Youth Exposed to Trauma. 3. Embodied
Health: The Effects of a MindBody Course for Medical Students. 4. Interoceptive
Awareness and Vegetable Intake After a Yoga and Stress Management Intervention.
5. Yoga Reduces Performance Anxiety in Adolescent Musicians. 6. Designing and
Implementing a Therapeutic Yoga Program for Older Women With Knee Osteoarthritis.
7. Yoga and Life Skills Eating Disorder Prevention Among 5th Grade Females: A
Controlled Trial. 8. A Randomized, Controlled Trial Comparing the Impact of Yoga
and Physical Education on the Emotional and Behavioral Functioning of Middle
School Children. 9. Feasibility of a Multisite, Community based Randomized Study
of Yoga and Wellness Education for Women With Breast Cancer Undergoing
Chemotherapy. 10. A Delphi Study for the Development of Protocol Guidelines for
Yoga Interventions in Mental Health. 11. Impact Investigation of Breathwalk Daily
Practice: CanadaIndia Collaborative Study. 12. Yoga Improves Distress, Fatigue,
and Insomnia in Older Veteran Cancer Survivors: Results of a Pilot Study. 13.
Assessment of Kundalini Mantra and Meditation as an Adjunctive Treatment With
Mental Health Consumers. 14. Kundalini Yoga Therapy Versus Cognitive Behavior
Therapy for Generalized Anxiety Disorder and Co-Occurring Mood Disorder. 15.
Baseline Differences in Women Versus Men Initiating Yoga Programs to Aid Smoking
Cessation: Quitting in Balance Versus QuitStrong. 16. Pranayam Practice: Impact
on Focus and Everyday Life of Work and Relationships. 17. Participation in a
Tailored Yoga Program is Associated With Improved Physical Health in Persons With
Arthritis. 18. Effects of Yoga on Blood Pressure: Systematic Review and
Meta-analysis. 19. A Quasi-experimental Trial of a Yoga based Intervention to
Reduce Stress and Promote Health and Well-being Among Middle School Educators.
20. A Systematic Review of Yoga-based Interventions for Objective and Subjective
Balance Measures. 21. Disparities in Yoga Use: A Multivariate Analysis of 2007
National Health Interview Survey Data. 22. Implementing Yoga Therapy Adapted for
Older Veterans Who Are Cancer Survivors. 23. Randomized, Controlled Trial of Yoga
for Women With Major Depressive Disorder: Decreased Ruminations as Potential
Mechanism for Effects on Depression? 24. Yoga Beyond the Metropolis: A Yoga
Telehealth Program for Veterans. 25. Yoga Practice Frequency, Relationship
Maintenance Behaviors, and the Potential Mediating Role of Relationally
Interdependent Cognition. 26. Effects of Medical Yoga in Quality of Life, Blood
Pressure, and Heart Rate in Patients With Paroxysmal Atrial Fibrillation. 27.
Yoga During School May Promote Emotion Regulation Capacity in Adolescents: A
Group Randomized, Controlled Study. 28. Integrated Yoga Therapy in a Single
Session as a Stress Management Technique in Comparison With Other Techniques. 29.
Effects of a Classroom-based Yoga Intervention on Stress and Attention in Second
and Third Grade Students. 30. Improving Memory, Attention, and Executive Function
in Older Adults with Yoga Therapy. 31. Reasons for Starting and Continuing Yoga.
32. Yoga and Stress Management May Buffer Against Sexual Risk-Taking Behavior
Increases in College Freshmen. 33. Whole-systems Ayurveda and Yoga Therapy for
Obesity: Outcomes of a Pilot Study. 34. Womens Phenomenological Experiences of
Exercise, Breathing, and the Body During Yoga for Smoking Cessation Treatment.
35. Mindfulness as a Tool for Trauma Recovery: Examination of a Gender-responsive
Trauma-informed Integrative Mindfulness Program for Female Inmates. 36. Yoga
After Stroke Leads to Multiple Physical Improvements. 37. Tele-Yoga in Patients
With Chronic Obstructive Pulmonary Disease and Heart Failure: A Mixed-methods
Study of Feasibility, Acceptability, and Safety. 38. Effects of an Ashtanga
Yoga-based Health and Wellness Curriculum on Physical and Emotional Well-being,
Engagement Toward School, and Academic Performance of K-6 Students. 39. Yoga as a
Facilitator for Participation Following an 8-week Yoga for Individuals With
Chronic Stroke. 40. Standardization of Design and Reporting of Yoga Interventions
for Musculoskeletal Conditions: A Delphi Approach. 41. Creating S.P.A.C.E.
Through Yoga: Africa Yoga Project Teachers Promote Personal Transformation,
Peaceful Communities, and Purpose-filled Service.
LA - eng
PT - Journal Article
PT - Meta-Analysis
PT - Randomized Controlled Trial
PL - United States
TA - Int J Yoga Therap
JT - International journal of yoga therapy
JID - 100965420
SB - IM
MH - *Anxiety/therapy
MH - Depressive Disorder, Major
MH - Humans
MH - National Institute of Arthritis and Musculoskeletal and Skin Diseases (U.S.)
MH - Pilot Projects
MH - *Quality of Life
MH - Yoga/psychology
EDAT- 2013/01/01 00:00
MHDA- 2016/04/24 06:00
CRDT- 2013/11/02 06:00
AID - 725531PU2R110135 [pii]
PST - ppublish
SO - Int J Yoga Therap. 2013;23 Suppl:32-53.

PMID- 22876439
OWN - NLM
STAT- MEDLINE
DA - 20120810
DCOM- 20120830
IS - 0255-2922 (Print)
IS - 0255-2922 (Linking)
VI - 32
IP - 2
DP - 2012 Jun
TI - Mortality and recurrence of vascular disease among stroke patients treated with
combined TCM therapy.
PG - 173-8
AB - OBJECTIVE: To confirm the long-term outcomes of stroke patients and determine
predicting factors for death, recurrence of vascular events and poor outcome
(either recurrence or death) after the use of combined TCM therapy. METHODS: This
was a retrospective hospital-based cohort study and was performed in the First
Affiliated Hospital of Tianjin University of Traditional Chinese Medicine in
Tianjin. All subjects with stroke consecutively admitted to an inpatient ward of
the Acupuncture Department from January 1, 2008, to December 31, 2008 were
retrospectively followed through one year. The main outcomes were either a
recurrence of vascular events, mortality or both. Risk factors were recorded from
medical records. Multivariate regression models were used to analyze predictors.
The following independent variables were used: age, gender, hypertension,
ischemic heart disease, atrial fibrillation, diabetes mellitus, carotid arterial
lesions and history of stroke. RESULTS: Four-hundred and five patients were
included. The 1-year mortality rate was 11.11%. 23.70% of the patients had a
recurrent vascular event, and 30.86% suffered a poor outcome. Multiple logistic
regression analysis found that previous stroke, and advanced age were predictors
of death within one year, Recurrence of vascular events was associated with
carotid arterial lesions, history of diabetes and previous stroke. Long-term poor
outcome was predicted by advanced age, history of diabetes, and previous stroke.
CONCLUSION: Age, previous stroke, carotid arterial lesions and diabetes history
seem to have different impacts on the three outcomes within one year. Our
findings provide important data for planning future hospital register studies of
stroke patients in TCM hospitals.
FAU - Zhao, Xiao-feng
AU - Zhao XF
AD - Institute of Acupuncture and Moxibustion, the First Affiliated Hospital of
Tianjin University of Traditional Chinese Medicine, China.
FAU - Su, Shi-jun
AU - Su SJ
FAU - Yun, Guo
AU - Yun G
FAU - Guo, Yun-hong
AU - Guo YH
FAU - Wang, Shu
AU - Wang S
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PL - China
TA - J Tradit Chin Med
JT - Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan /
sponsored by All-China Association of Traditional Chinese Medicine, Academy of
Traditional Chinese Medicine
JID - 8211546
SB - IM
MH - Adult
MH - Aged
MH - Aged, 80 and over
MH - Cohort Studies
MH - Female
MH - Humans
MH - Logistic Models
MH - Male
MH - *Medicine, Chinese Traditional
MH - Middle Aged
MH - Recurrence
MH - Retrospective Studies
MH - Stroke/*drug therapy/mortality
MH - Vascular Diseases/*etiology
EDAT- 2012/08/11 06:00
MHDA- 2012/08/31 06:00
CRDT- 2012/08/11 06:00
PST - ppublish
SO - J Tradit Chin Med. 2012 Jun;32(2):173-8.

PMID- 22875558
OWN - NLM
STAT- MEDLINE
DA - 20120809
DCOM- 20120906
LR - 20121220
IS - 1078-6791 (Print)
IS - 1078-6791 (Linking)
VI - 18
IP - 3
DP - 2012 May-Jun
TI - Tai chi exercise for patients with heart disease: a systematic review of
controlled clinical trials.
PG - 16-22
AB - CONTEXT: To summarize and evaluate the available evidence from controlled
clinical trials of tai chi (TC) exercise for patients with heart disease. SEARCH
METHODS: Fourteen databases were searched up to November 2010 with the terms tai
chi, taichi, tai ji, taiji, taijichuan, cardiac, heart, coronary, myocardial, and
atrial fibrillation in the title, abstract, or key words. No language
restrictions were imposed. The quality and validity of randomized clinical trials
(RCTs) were evaluated using the Jadad Scale. The strength of the evidence for all
included studies was evaluated using the Oxford Centre for Evidence-based
Medicine Levels of Evidence. RESULTS: Nine studies including 5 RCTs and 4
nonrandomized controlled clinical trials met the inclusion criteria. Three
studies examined the effectiveness of TC exercise for patients with chronic heart
failure (CHF), and 6 studies examined the effectiveness of TC exercise among
patients with coronary heart disease (CHD). Overall, these studies demonstrated
favorable effects of TC exercise for the patients with heart disease.
CONCLUSIONS: The existing evidence suggests that TC exercise is a good option for
heart patients with very limited exercise tolerance and can be an adjunct to
rehabilitation programs for patients with CHD or CHF.
FAU - Ng, Siu-Man
AU - Ng SM
AD - Centre on Behavioral Health and Department of Social Work and Social
Administration, University of Hong Kong.
FAU - Wang, Chong-Wen
AU - Wang CW
FAU - Ho, Rainbow Tin-Hung
AU - Ho RT
FAU - Ziea, Tat-Chi
AU - Ziea TC
FAU - He, J
AU - He J
FAU - Wong, Vivian Chi-Woon
AU - Wong VC
FAU - Chan, Cecilia Lai-Wan
AU - Chan CL
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PT - Review
PL - United States
TA - Altern Ther Health Med
JT - Alternative therapies in health and medicine
JID - 9502013
SB - IM
EIN - Altern Ther Health Med. 2012 Nov-Dec;18(6):79. Tin-Hung Ho, Rainbow [corrected to
Ho, Rainbow Tin-Hung]; Tat-Chi Ziea, Eric [corrected to Ziea, Tat-Chi]; He, J
[removed]; Chi-Woon Taam Wong, Vivian [corrected to Wong, Vivian Chi-Woon];
Lai-Wan Chan, Cecilia [corrected to Chan, Cecilia Lai-Wan]
MH - Activities of Daily Living
MH - Controlled Clinical Trials as Topic
MH - Coronary Disease/*rehabilitation
MH - *Evidence-Based Medicine
MH - Health Behavior
MH - Humans
MH - Myocardial Infarction/rehabilitation
MH - Outcome Assessment (Health Care)
MH - *Quality of Life
MH - Randomized Controlled Trials as Topic
MH - Research Design
MH - *Tai Ji
EDAT- 2012/08/10 06:00
MHDA- 2012/09/07 06:00
CRDT- 2012/08/10 06:00
PST - ppublish
SO - Altern Ther Health Med. 2012 May-Jun;18(3):16-22.

PMID- 22741473
OWN - NLM
STAT- MEDLINE
DA - 20120629
DCOM- 20120828
IS - 1001-5302 (Print)
IS - 1001-5302 (Linking)
VI - 37
IP - 1
DP - 2012 Jan
TI - [Quality assessment of randomized controlled trials on wenxin granule for
treatment of atrial fibrillation].
PG - 109-14
AB - OBJECTIVE: To investigate the statement on randomized controlled trials on Wenxin
granule for treatment of atrial fibrillation and to judge whether those trials
could offer high quality evidence or not, thus improve design level and quality.
METHOD: RCTs were searched from home and abroad about atrial fibrillation treated
with Wenxin granule, which reported before October, 2010. Jadad scale and CONSORT
statement were used. RESULT: There were 66 RCTs retrieved that met inclusion
criteria. Using Jadad rating scale, only 2 literatures gain score 4 and 1
literature gains score 3, 54 literatures gain score 2, 7 literatures gain score
1, 2 literatures gain score 0. Only 2 literatures described random number table
as the method of grouping. None of the RCTs was reported the allocation
concealment. Only 1 literature was used blinding. Fifty-nine literatures were
mentioned the lost to follow-up conditions. According to the CONSORT standards,
only six literatures (9.1%) mentioned the method of generating the random
sequence. Four literatures (6.1%) were quasi-random. Nineteen literatures (28.8%)
had inclusion criteria. Six literatures (9.1%) had the follow-up record. Fifty
one literatures (77.3%) described the adverse events. None had the estimation of
the sample size, intention-to-treat analysis and stratified analysis. None had
the ethical approval or informed consent. CONCLUSION: The quality of clinical
trials of Wenxin granule in treating atrial fibrillation needs to be improved.
FAU - Liu, Weimin
AU - Liu W
AD - Institute of Basic Research In Clinical Medicine, China Academy of Chinese
Medical Sciences, Beijing 100700, China. liuweimin68@yahoo.com.cn
FAU - Jiang, Rui
AU - Jiang R
FAU - Ding, Shasha
AU - Ding S
FAU - Fu, Wei
AU - Fu W
FAU - Wang, Shuqin
AU - Wang S
FAU - Li, Xue
AU - Li X
FAU - Kang, Jing
AU - Kang J
FAU - Wu, Dongning
AU - Wu D
FAU - Liu, Bo
AU - Liu B
FAU - Mao, Wenchao
AU - Mao W
FAU - He, Liyun
AU - He L
FAU - Liu, Baoyan
AU - Liu B
LA - chi
PT - English Abstract
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PL - China
TA - Zhongguo Zhong Yao Za Zhi
JT - Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese
materia medica
JID - 8913656
RN - 0 (Drugs, Chinese Herbal)
SB - IM
MH - Atrial Fibrillation/*drug therapy
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Humans
MH - Randomized Controlled Trials as Topic
EDAT- 2012/06/30 06:00
MHDA- 2012/08/29 06:00
CRDT- 2012/06/30 06:00
PST - ppublish
SO - Zhongguo Zhong Yao Za Zhi. 2012 Jan;37(1):109-14.

PMID- 22419421
OWN - NLM
STAT- MEDLINE
DA - 20120315
DCOM- 20120710
IS - 0192-415X (Print)
IS - 0192-415X (Linking)
VI - 40
IP - 2
DP - 2012
TI - A systematic review of the effectiveness of qigong exercise in cardiac
rehabilitation.
PG - 255-67
AB - The objective of this study was to assess evidence for the efficacy and
effectiveness of Chinese qigong exercise in rehabilitative programs among cardiac
patients. Thirteen databases were searched through to November 2010, and all
controlled clinical trials on Chinese qigong exercise among patients with chronic
heart diseases were included. For each included study, data was extracted and
validity was assessed. Study quality was evaluated and summarized using both the
Jadad Scale and the criteria for levels of evidence. Seven randomized controlled
trials (RCTs) and one non-randomized controlled clinical trial (CCT) published
between 1988 and 2007 met the inclusion criteria. In total, these studies covered
540 patients with various chronic heart diseases including atrial fibrillation,
coronary artery disease, myocardial infarct, valve replacement, and ischemic
heart disease. Outcome measures emerged in these studies included subjective
outcomes such as symptoms and quality of life; and objective outcomes such as
blood pressure, ECG findings, and exercise capacity, physical activity, balance,
co-ordination, heart rate, and oxygen uptake. Overall, these studies suggest that
Chinese qigong exercise seems to be an optimal option for patients with chronic
heart diseases who were unable to engage in other forms of physical activity;
however, its efficacy and effectiveness in cardiac rehabilitation programs should
be further tested.
FAU - Chan, Cecilia Lai-Wan
AU - Chan CL
AD - Centre on Behavioral Health, University of Hong Kong, 5 Sassoon Road, Pokfulam,
Hong Kong SAR, China.
FAU - Wang, Chong-Wen
AU - Wang CW
FAU - Ho, Rainbow Tin-Hung
AU - Ho RT
FAU - Ho, Andy Hau-Yan
AU - Ho AH
FAU - Ziea, Eric Tat-Chi
AU - Ziea ET
FAU - Taam Wong, Vivian Chi-Woon
AU - Taam Wong VC
FAU - Ng, Siu-Man
AU - Ng SM
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PT - Review
PL - Singapore
TA - Am J Chin Med
JT - The American journal of Chinese medicine
JID - 7901431
SB - IM
MH - *Breathing Exercises
MH - Clinical Trials as Topic
MH - Heart/physiopathology
MH - Heart Diseases/physiopathology/*rehabilitation
MH - Humans
EDAT- 2012/03/16 06:00
MHDA- 2012/07/11 06:00
CRDT- 2012/03/16 06:00
AID - S0192415X12500206 [pii]
AID - 10.1142/S0192415X12500206 [doi]
PST - ppublish
SO - Am J Chin Med. 2012;40(2):255-67.

PMID- 22072550
OWN - NLM
STAT- MEDLINE
DA - 20120607
DCOM- 20121002
LR - 20141120
IS - 1099-1573 (Electronic)
IS - 0951-418X (Linking)
VI - 26
IP - 6
DP - 2012 Jun
TI - Frequency-dependent electrophysiological remodeling of the AV node by
hydroalcohol extract of Crocus sativus L. (saffron) during experimental atrial
fibrillation: the role of endogenous nitric oxide.
PG - 826-32
LID - 10.1002/ptr.3643 [doi]
AB - The study assessed the hydroalcohol extract effects of Crocus sativus L.
(saffron) on (i) the basic and rate-dependent electrophysiological properties of
the AV node, (ii) remodeling of the AV node during experimental atrial
fibrillation (AF) and (iii) the role of nitric oxide (NO) in the effects of
saffron on the AV node. Stimulation protocols in isolated AV node were used to
quantify AV nodal recovery, facilitation and fatigue in four groups of rabbits (n
= 8-16 per group). In addition, the nodal response to AF was evaluated at
multiple cycle lengths and during AF. Saffron had a depressant effect on AV nodal
rate-dependent properties; further, it increased Wenckebach block cycle length,
functional refractory period, facilitation and fatigue (p < 0.05). A NO-synthase
inhibitor (L-NAME) prevented the depressant effects of saffron on the AV node (p
< 0.05). Saffron increased the zone of concealment in experimental AF (p < 0.05).
The present research showed, for the first time, established electrophysiological
remodeling of the AV node during AF by saffron. Saffron increased the AV nodal
refractoriness and zone of concealment. These depressant effects of saffron were
mediated by endogenous NO.
CI - Copyright (c) 2011 John Wiley & Sons, Ltd.
FAU - Khori, Vahid
AU - Khori V
AD - Golestan Cardiovascular Research Center, Golestan University of Medical Sciences,
Gorgan, Iran.
FAU - Alizadeh, Ali Mohammad
AU - Alizadeh AM
FAU - Yazdi, Hamidreza
AU - Yazdi H
FAU - Rakhshan, Elnaz
AU - Rakhshan E
FAU - Mirabbasi, Abbas
AU - Mirabbasi A
FAU - Changizi, Shima
AU - Changizi S
FAU - Mazandarani, Masumeh
AU - Mazandarani M
FAU - Nayebpour, Mohsen
AU - Nayebpour M
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
DEP - 20111110
PL - England
TA - Phytother Res
JT - Phytotherapy research : PTR
JID - 8904486
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Plant Extracts)
RN - 059QF0KO0R (Water)
RN - 31C4KY9ESH (Nitric Oxide)
RN - 3K9958V90M (Ethanol)
RN - V55S2QJN2X (NG-Nitroarginine Methyl Ester)
SB - IM
MH - Animals
MH - Anti-Arrhythmia Agents/pharmacology
MH - Atrial Fibrillation/*physiopathology
MH - Atrioventricular Node/*drug effects/metabolism/physiopathology
MH - Crocus/*chemistry
MH - *Electrophysiological Phenomena
MH - Ethanol
MH - Fatigue/chemically induced/physiopathology
MH - Heart Block/physiopathology
MH - Heart Rate
MH - In Vitro Techniques
MH - Male
MH - NG-Nitroarginine Methyl Ester/pharmacology
MH - Nitric Oxide/antagonists & inhibitors/*metabolism
MH - Plant Extracts/administration & dosage/chemistry/pharmacology
MH - Rabbits
MH - Water
EDAT- 2011/11/11 06:00
MHDA- 2012/10/04 06:00
CRDT- 2011/11/11 06:00
PHST- 2011/04/10 [received]
PHST- 2011/07/11 [revised]
PHST- 2011/07/11 [accepted]
PHST- 2011/11/10 [aheadofprint]
AID - 10.1002/ptr.3643 [doi]
PST - ppublish
SO - Phytother Res. 2012 Jun;26(6):826-32. doi: 10.1002/ptr.3643. Epub 2011 Nov 10.

PMID- 21823296
OWN - NLM
STAT- MEDLINE
DA - 20110809
DCOM- 20110906
IS - 0255-2930 (Print)
IS - 0255-2930 (Linking)
VI - 31
IP - 7
DP - 2011 Jul
TI - [Case of atrial fibrillation].
PG - 645
FAU - Yang, Zhen-Jie
AU - Yang ZJ
AD - gancao8314@163.com
FAU - Wu, Fu-Dong
AU - Wu FD
FAU - Wang, Rui
AU - Wang R
LA - chi
PT - Case Reports
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PL - China
TA - Zhongguo Zhen Jiu
JT - Zhongguo zhen jiu = Chinese acupuncture & moxibustion
JID - 8600658
SB - IM
MH - *Acupuncture Therapy
MH - Aged
MH - Atrial Fibrillation/physiopathology/*therapy
MH - Humans
MH - Male
EDAT- 2011/08/10 06:00
MHDA- 2011/09/07 06:00
CRDT- 2011/08/10 06:00
PST - ppublish
SO - Zhongguo Zhen Jiu. 2011 Jul;31(7):645.

PMID- 21385466
OWN - NLM
STAT- MEDLINE
DA - 20110325
DCOM- 20110825
LR - 20151119
IS - 1472-6882 (Electronic)
IS - 1472-6882 (Linking)
VI - 11
DP - 2011
TI - Physical conditioning and mental stress reduction--a randomised trial in patients
undergoing cardiac surgery.
PG - 20
LID - 10.1186/1472-6882-11-20 [doi]
AB - BACKGROUND: Preoperative anxiety and physical unfitness have been shown to have
adverse effects on recovery from cardiac surgery. This study involving cardiac
surgery patients was primarily aimed at assessing the feasibility of delivering
physical conditioning and stress reduction programs within the public hospital
setting. Secondary aims were to evaluate the effect of these programs on quality
of life (QOL), rates of postoperative atrial fibrillation (AF) and length of stay
(LOS) in hospital. METHODS: Elective patients scheduled for coronary artery
bypass graft and/or valve surgery at a public hospital in Melbourne, Australia
were enrolled. Patients were randomized to receive either holistic therapy (HT)
or usual care (UC). HT consisted of a series of light physical exercise sessions
together with a mental stress reduction program administered in an outpatient
setting for the first two weeks after placement on the waiting list for surgery.
A self-administered SF-36 questionnaire was used to measure QOL and hospital
records to collect data on LOS and rate of postoperative AF. RESULTS: The study
population comprised 117 patients of whom 60 received HT and 57 received UC. Both
programs were able to be delivered within the hospital setting but ongoing
therapy beyond the two week duration of the program was not carried out due to
long waiting periods and insufficient resources. HT, as delivered in this study,
compared to UC did not result in significant changes in QOL, LOS or AF incidence.
CONCLUSIONS: Preoperative holistic therapy can be delivered in the hospital
setting, although two weeks is insufficient to provide benefits beyond usual care
on QOL, LOS or postoperative AF. Further research is now required to determine
whether a similar program of longer duration, or targeted to high risk patients
can provide measurable benefits. TRIAL REGISTRATION: This trial was conducted as
part of a larger study and according to the principles contained in the CONSORT
statement 2001.
FAU - Rosenfeldt, Franklin
AU - Rosenfeldt F
AD - Cardiac Surgical Research Unit, Alfred Hospital, Department of Surgery, Monash
University, Baker IDI Institute Melbourne, Australia. f.rosenfeldt@alfred.org.au
FAU - Braun, Lesley
AU - Braun L
FAU - Spitzer, Ondine
AU - Spitzer O
FAU - Bradley, Scott
AU - Bradley S
FAU - Shepherd, Judy
AU - Shepherd J
FAU - Bailey, Michael
AU - Bailey M
FAU - van der Merwe, Juliana
AU - van der Merwe J
FAU - Leong, Jee-Yoong
AU - Leong JY
FAU - Esmore, Donald
AU - Esmore D
LA - eng
PT - Journal Article
PT - Randomized Controlled Trial
PT - Research Support, Non-U.S. Gov't
DEP - 20110309
PL - England
TA - BMC Complement Altern Med
JT - BMC complementary and alternative medicine
JID - 101088661
SB - IM
MH - Aged
MH - Atrial Fibrillation/etiology/therapy
MH - Cardiac Surgical Procedures/*psychology
MH - Coronary Artery Bypass
MH - Evaluation Studies as Topic
MH - *Exercise Therapy
MH - Female
MH - Heart Diseases/surgery
MH - Heart Valves/surgery
MH - *Holistic Health
MH - Humans
MH - Length of Stay
MH - Male
MH - Middle Aged
MH - *Mind-Body Therapies
MH - Outcome Assessment (Health Care)
MH - *Physical Fitness
MH - Postoperative Complications/therapy
MH - Preoperative Care/*methods
MH - Quality of Life
MH - Standard of Care
MH - Stress, Psychological/*therapy
MH - Surveys and Questionnaires
PMC - PMC3063826
OID - NLM: PMC3063826
EDAT- 2011/03/10 06:00
MHDA- 2011/08/27 06:00
CRDT- 2011/03/10 06:00
PHST- 2010/06/28 [received]
PHST- 2011/03/09 [accepted]
PHST- 2011/03/09 [aheadofprint]
AID - 1472-6882-11-20 [pii]
AID - 10.1186/1472-6882-11-20 [doi]
PST - epublish
SO - BMC Complement Altern Med. 2011 Mar 9;11:20. doi: 10.1186/1472-6882-11-20.

PMID- 21302500
OWN - NLM
STAT- MEDLINE
DA - 20110208
DCOM- 20130204
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 30
IP - 12
DP - 2010 Dec
TI - [Exploration on current clinical management of cardiovascular diseases].
PG - 1320-4
AB - Dramatic advances in the treatment of cardiovascular disease were witnessed in
recent years, however, there are still some problems needed to be explored. The
related issues in terms of coronary heart disease, atrial fibrillation and
chronic heart failure were discussed in this paper, and the latest progress of
integrative medical treatment on them were reviewed as well.
FAU - Zhao, Fu-hai
AU - Zhao FH
AD - Cardiovascular Center, Xiyuan Hospital, China Academy of Chinese Medical
Sciences, Beijing 100091. xahappysea@yahoo.com.cn
LA - chi
PT - English Abstract
PT - Journal Article
PL - China
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
RN - 0 (Drugs, Chinese Herbal)
SB - IM
MH - Atrial Fibrillation/therapy
MH - Cardiovascular Diseases/*therapy
MH - Chronic Disease
MH - Coronary Disease/therapy
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Heart Failure/therapy
MH - Humans
MH - *Phytotherapy
EDAT- 2011/02/10 06:00
MHDA- 2013/02/05 06:00
CRDT- 2011/02/10 06:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Dec;30(12):1320-4.

PMID- 21110181
OWN - NLM
STAT- MEDLINE
DA - 20101126
DCOM- 20110330
LR - 20151119
IS - 1672-0415 (Print)
IS - 1672-0415 (Linking)
VI - 16
IP - 6
DP - 2010 Dec
TI - Evidence-based practice method of integrative Chinese and Western medicine based
on literature retrieval through PICO question and complementary and alternative
medicine topics.
PG - 542-8
LID - 10.1007/s11655-010-0570-5 [doi]
AB - An evidence-based practice method according to literature retrieval through PICO
(Patients, Intervention, Comparison, Outcome) questions and complementary and
alternative medicine (CAM) topics, which can obtain helpful evidence for guiding
clinical practice, was introduced with a practical example in this paper. The
knowledge of diseases and Western medicine treatment can be acquired by
literature retrieval through PICO question, while searching by CAM topics may
provide evidence for Chinese medicine (CM). Thus the author held that literature
retrieval through both PICO question and CAM topics was an ideal evidence-based
practice method for integrative Chinese and Western medicine (ICWM). However,
since the standard in CM evidence hierarchy is still under study, the value of
the CAM thematic retrieval method remains very limited. In the future, studies on
the definition and hierarchy of CM evidences and the herb-drug interaction
between Western and Chinese medicine during a combination therapy should be
strengthened to improve the status of ICWM evidence-based practice.
FAU - Yan, Xiu-feng
AU - Yan XF
AD - Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053,
China.
FAU - Ni, Qing
AU - Ni Q
FAU - Wei, Jun-ping
AU - Wei JP
FAU - Xu, Hao
AU - Xu H
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PT - Review
DEP - 20101126
PL - China
TA - Chin J Integr Med
JT - Chinese journal of integrative medicine
JID - 101181180
SB - IM
MH - Atrial Fibrillation/physiopathology/therapy
MH - Complementary Therapies/*methods
MH - Evidence-Based Medicine/*methods
MH - Heart Rate/physiology
MH - Herb-Drug Interactions
MH - Humans
MH - Integrative Medicine/*methods
MH - Internet
MH - Medicine, Chinese Traditional/*methods
MH - *Surveys and Questionnaires
MH - Treatment Outcome
EDAT- 2010/11/27 06:00
MHDA- 2011/03/31 06:00
CRDT- 2010/11/27 06:00
PHST- 2010/06/07 [received]
PHST- 2010/11/26 [aheadofprint]
AID - 10.1007/s11655-010-0570-5 [doi]
PST - ppublish
SO - Chin J Integr Med. 2010 Dec;16(6):542-8. doi: 10.1007/s11655-010-0570-5. Epub
2010 Nov 26.

PMID- 20872121
OWN - NLM
STAT- MEDLINE
DA - 20100927
DCOM- 20110201
LR - 20131121
IS - 1672-0415 (Print)
IS - 1672-0415 (Linking)
VI - 16
IP - 5
DP - 2010 Oct
TI - Clinical observation on the treatment of atrial fibrillation with amiodarone
combined with Shenmai Injection ().
PG - 453-6
LID - 10.1007/s11655-010-0540-y [doi]
AB - OBJECTIVE: To observe the therapeutic efficacy and safety of amiodarone combined
with Shenmai Injection () on atrial fibrillation. METHODS: A total of 351
patients with atrial fibrillation caused by cardiovascular diseases and
idiopathic atrial fibrillation were assigned to amiodarone group (control group,
128 cases) and amiodarone combined with Shenmai Injection group (treatment group,
223 cases). The patients in the control group received intravenous injection of
150 mg amiodarone in 10 min, followed by intravenous drip infusion at 1 mg /min
and 6 h later at 0.5 mg /min until 48 h or cardioversion. The patients in the
treatment group received the same treatment of amiodarone, while in addition,
they received an injection of Shenmai Injection of 100 mL simultaneously. Blood
pressure, ventricular rate, and cardioversion were observed. RESULTS: The total
efficiency rate was 98% (control group) and 99% (treatment group) (P>0.05). The
mean ventricular rate decreased 23% and 31% in the control group and the
treatment group, respectively (P<0.05). The mean cardioversion time of the two
groups was 570+/-211 min and 351+/-123 min, respectively (P<0.05). Only mild side
effects were observed in both groups. CONCLUSION: Compared with amiodarone,
amiodarone combined with Shenmai Injection takes effect more quickly with low
side effects on the treatment of atrial fibrillation.
FAU - Deng, Min
AU - Deng M
AD - Emergency Medicine Department, Integrated Chinese and Western Medicine Hospital,
Zhejiang University of Traditional Chinese Medicine, Hangzhou, China.
dengmin136@126.com
FAU - Sui, Xiang-qian
AU - Sui XQ
FAU - Zhu, Shi-bing
AU - Zhu SB
FAU - Ma, Wei
AU - Ma W
FAU - Xu, Ying
AU - Xu Y
FAU - Chen, Zhi-ming
AU - Chen ZM
LA - eng
PT - Journal Article
DEP - 20100925
PL - China
TA - Chin J Integr Med
JT - Chinese journal of integrative medicine
JID - 101181180
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Drug Combinations)
RN - 0 (Drugs, Chinese Herbal)
RN - 0 (fructus schizandrae, radix ginseng, radix ophiopogonis drug combination)
RN - N3RQ532IUT (Amiodarone)
SB - IM
MH - Aged
MH - Aged, 80 and over
MH - Amiodarone/administration & dosage/adverse effects/*therapeutic use
MH - Anti-Arrhythmia Agents/administration & dosage/adverse effects/*therapeutic use
MH - Atrial Fibrillation/*drug therapy
MH - Drug Combinations
MH - Drugs, Chinese Herbal/*administration & dosage/adverse effects/*therapeutic use
MH - Female
MH - Humans
MH - Male
MH - Middle Aged
EDAT- 2010/09/28 06:00
MHDA- 2011/02/02 06:00
CRDT- 2010/09/28 06:00
PHST- 2010/02/08 [received]
PHST- 2010/09/25 [aheadofprint]
AID - 10.1007/s11655-010-0540-y [doi]
PST - ppublish
SO - Chin J Integr Med. 2010 Oct;16(5):453-6. doi: 10.1007/s11655-010-0540-y. Epub
2010 Sep 25.

PMID- 19447272
OWN - NLM
STAT- MEDLINE
DA - 20090518
DCOM- 20090930
IS - 1532-6586 (Electronic)
IS - 0161-4754 (Linking)
VI - 32
IP - 4
DP - 2009 May
TI - Treatment of paroxysmal supraventricular tachycardia using instrument-assisted
manipulation of the fourth rib.
PG - 326; author reply 326-7
LID - 10.1016/j.jmpt.2009.03.004 [doi]
FAU - Osterbauer, Paul J
AU - Osterbauer PJ
FAU - Elkington, William C
AU - Elkington WC
LA - eng
PT - Comment
PT - Letter
PL - United States
TA - J Manipulative Physiol Ther
JT - Journal of manipulative and physiological therapeutics
JID - 7807107
SB - IM
CON - J Manipulative Physiol Ther. 2008 Jun;31(5):389-91. PMID: 18558281
MH - Atrial Fibrillation/diagnosis
MH - Chiropractic/*methods
MH - Humans
MH - Interdisciplinary Communication
MH - *Patient Care Team
MH - Tachycardia, Paroxysmal/diagnosis/*therapy
EDAT- 2009/05/19 09:00
MHDA- 2009/10/01 06:00
CRDT- 2009/05/19 09:00
PHST- 2008/09/09 [received]
AID - S0161-4754(09)00091-8 [pii]
AID - 10.1016/j.jmpt.2009.03.004 [doi]
PST - ppublish
SO - J Manipulative Physiol Ther. 2009 May;32(4):326; author reply 326-7. doi:
10.1016/j.jmpt.2009.03.004.

PMID- 18928392
OWN - NLM
STAT- MEDLINE
DA - 20081107
DCOM- 20081229
IS - 1557-7708 (Electronic)
IS - 1075-5535 (Linking)
VI - 14
IP - 8
DP - 2008 Oct
TI - Omega-3 fatty acid: a role in the management of cardiac arrhythmias?
PG - 965-74
LID - 10.1089/acm.2007.0765 [doi]
AB - OBJECTIVE: The objective of this study was to review and evaluate published
evidence on the use of omega-3 fatty acid in the prevention and treatment of
atrial and ventricular arrhythmias. Postulated mechanisms of the antiarrhythmic
effects of omega-3 fatty acid are discussed. DATA SOURCES: Peer-reviewed
articles/abstracts published in English language were identified from MEDLINE and
Current Content databases (both 1966 to May 15, 2008) using the search terms fish
oil, omega-3 fatty acid, sudden death, ventricular arrhythmia, and atrial
fibrillation. Citations from available articles were also reviewed for additional
references. Abstracts presented at recent professional meetings are also
reviewed. STUDY SELECTION AND DATA EXTRACTION: Observational studies and
interventional clinical studies published on omega-3 fatty acid or fish
consumption and atrial or ventricular arrhythmias and sudden cardiac death are
selected. The design and results of the studies are evaluated. DATA SYNTHESIS:
Several mechanisms have been postulated to explain the antiarrhythmic effect of
omega-3 fatty acid. It is believed that omega-3 fatty acid has an indirect effect
on the autonomic nervous system, inhibits the fast, voltage-dependent sodium and
L-type calcium channels, restores a favorable omega-6 fatty acid/omega-3 fatty
acid balance, and exerts anti-inflammatory effects. While the majority of
observational evidence demonstrated that increased consumption of omega-3 fatty
acid was associated with reduction in risk of sudden cardiac death, in
ventricular arrhythmia, there was evidence suggesting that omega-3 fatty acid in
patients experiencing nonischemic ventricular arrhythmia may be proarrhythmic.
Other studies demonstrated a neutral effect. In terms of management of atrial
fibrillation, short-term small-scale studies demonstrated that the use of omega-3
fatty acid preoperatively may reduce the incidence of postoperative atrial
fibrillation. However, such observations were not consistent with those reported
from retrospective cohorts. CONCLUSIONS: Additional studies are needed to
evaluate the effect of omega-3 fatty acid before it can be routinely recommended
for the management of arrhythmia.
FAU - Cheng, Judy W M
AU - Cheng JW
AD - Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health
Sciences, Boston, MA 02115, USA. judy.cheng@mcphs.edu
FAU - Santoni, Francesco
AU - Santoni F
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PT - Review
PL - United States
TA - J Altern Complement Med
JT - Journal of alternative and complementary medicine (New York, N.Y.)
JID - 9508124
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Fatty Acids, Omega-3)
SB - IM
MH - Anti-Arrhythmia Agents/pharmacology/*therapeutic use
MH - Arrhythmias, Cardiac/*drug therapy/prevention & control
MH - Atrial Fibrillation/*drug therapy/prevention & control
MH - Clinical Trials as Topic
MH - Dietary Supplements
MH - *Evidence-Based Medicine
MH - Fatty Acids, Omega-3/pharmacology/*therapeutic use
MH - Heart Atria/drug effects
MH - Heart Rate/drug effects
MH - Humans
MH - Research Design
RF - 43
EDAT- 2008/10/22 09:00
MHDA- 2008/12/30 09:00
CRDT- 2008/10/22 09:00
AID - 10.1089/acm.2007.0765 [doi]
PST - ppublish
SO - J Altern Complement Med. 2008 Oct;14(8):965-74. doi: 10.1089/acm.2007.0765.

PMID- 18616066
OWN - NLM
STAT- MEDLINE
DA - 20080711
DCOM- 20080923
IS - 1078-6791 (Print)
IS - 1078-6791 (Linking)
VI - 14
IP - 4
DP - 2008 Jul-Aug
TI - The efficacy of healing touch in coronary artery bypass surgery recovery: a
randomized clinical trial.
PG - 24-32
AB - CONTEXT: The use of complementary therapies in conjunction with conventional care
has great potential to address patient pain, complication rates, and recovery
time. Few studies of such therapies have been conducted in hospital settings
where some of the most stressful procedures are performed on a regular basis.
OBJECTIVE: We hypothesized that patients receiving healing touch (HT) would see
improved outcomes. DESIGN: Patients were randomized into 1 of 3 treatment groups:
no intervention, partial intervention (visitors), and an HT group. SETTING: This
study was conducted in an acute-care hospital in a large metropolitan area.
PATIENTS OR OTHER PARTICIPANTS: Patients undergoing first-time elective coronary
artery bypass surgery were invited to participate. There were 237 study subjects.
INTERVENTION: HT is an energy-based therapeutic approach to healing that arose
out of nursing in the early 1980s. HT aids relaxation and supports the body's
natural healing process. MAIN OUTCOME MEASURES: This study consisted of 6 outcome
measures: postoperative length of stay, incidence of postoperative atrial
fibrillation, use of anti-emetic medication, amount of narcotic pain medication,
functional status, and anxiety. RESULTS: Analysis was conducted for all patients
and separately by inpatient/outpatient status. Though no significant decrease in
the use of pain medication, anti-emetic medication, or incidence of atrial
fibrillation was observed, significant differences were noted in anxiety scores
and length ofstay. All HT patients showed a greater decrease in anxiety scores
when compared to the visitor and control groups. In addition, there was a
significant difference in outpatient HT length of stay when compared to the
visitor and control groups.
FAU - MacIntyre, Barb
AU - MacIntyre B
AD - Cardiovascular Telemetry, HealthEast Saint Joseph's Hospital, St Paul, Minnesota,
USA.
FAU - Hamilton, Jane
AU - Hamilton J
FAU - Fricke, Theresa
AU - Fricke T
FAU - Ma, Wenjun
AU - Ma W
FAU - Mehle, Susan
AU - Mehle S
FAU - Michel, Matt
AU - Michel M
LA - eng
PT - Journal Article
PT - Randomized Controlled Trial
PL - United States
TA - Altern Ther Health Med
JT - Alternative therapies in health and medicine
JID - 9502013
SB - IM
MH - Aged
MH - Anxiety/etiology/*prevention & control
MH - Coronary Artery Bypass/*rehabilitation
MH - Female
MH - *Holistic Health
MH - Humans
MH - Length of Stay/statistics & numerical data
MH - Male
MH - Middle Aged
MH - Pain Measurement/methods
MH - Pain, Postoperative/therapy
MH - Patient Satisfaction
MH - Postoperative Care/*methods
MH - Postoperative Complications/*therapy
MH - Recovery of Function
MH - Therapeutic Touch/*methods
MH - Treatment Outcome
EDAT- 2008/07/12 09:00
MHDA- 2008/09/24 09:00
CRDT- 2008/07/12 09:00
PST - ppublish
SO - Altern Ther Health Med. 2008 Jul-Aug;14(4):24-32.

PMID- 18356799
OWN - NLM
STAT- MEDLINE
DA - 20080321
DCOM- 20080722
LR - 20150615
IS - 0964-5284 (Print)
IS - 0964-5284 (Linking)
VI - 26
IP - 1
DP - 2008 Mar
TI - Possible effects of acupuncture on atrial fibrillation and post-herpetic
neuralgia--a case report.
PG - 51-6
AB - A 72 year old female with a main complaint of severe post-herpetic neuralgia and
a secondary complaint of atrial fibrillation (AF) received two series of
acupuncture treatments totalling 20 treatments over a four month period. Her
standard medical treatment remained unchanged. The primary focus of the
acupuncture was pain relief; however, two acupuncture points (PC6, SP4) were
included in both treatment series because of possible effects on both costal or
chest pain and cardiac arrhythmias, according to Traditional Chinese Medicine
(TCM) teaching and limited research. As recorded by her pacemaker, estimated
weekly episodes of AF in the patient decreased significantly, and percentage time
in AF decreased with borderline statistical significance, from the pretreatment
estimates during the second series of treatments (weekly AF episode estimates:
pretreatment=71.4; second series=16.5, difference estimates=-54.9, 95% CI -6.5 to
-103.3, P=0.02; percentage time in AF estimates: pretreatment=30.6; 2 second
series=18.0, difference estimates=-12.6, 95% CI 0.9 to -26.0, P=0.08). The pain
levels were also significantly reduced following the acupuncture treatment series
by more than 67%. Further studies are warranted to further explore these
observations of a possible effect of acupuncture on both atrial fibrillation and
post-herpetic neuralgia.
FAU - Valaskatgis, Peter
AU - Valaskatgis P
AD - New England School of Acupuncture, Newton, MA, USA. peterval@comcast.net
FAU - Macklin, Eric A
AU - Macklin EA
FAU - Schachter, Steven C
AU - Schachter SC
FAU - Wayne, Peter M
AU - Wayne PM
LA - eng
GR - 5 U19 AT002022-02/AT/NCCIH NIH HHS/United States
PT - Case Reports
PT - Journal Article
PT - Research Support, N.I.H., Extramural
PT - Research Support, U.S. Gov't, P.H.S.
PL - England
TA - Acupunct Med
JT - Acupuncture in medicine : journal of the British Medical Acupuncture Society
JID - 9304117
SB - IM
MH - Acupuncture Analgesia
MH - Acupuncture Therapy/*methods
MH - Aged
MH - Atrial Fibrillation/etiology/*therapy
MH - Cardiac Pacing, Artificial/adverse effects
MH - Facial Pain/etiology/*therapy
MH - Female
MH - Humans
MH - Neuralgia, Postherpetic/complications/*therapy
MH - Treatment Outcome
EDAT- 2008/03/22 09:00
MHDA- 2008/07/23 09:00
CRDT- 2008/03/22 09:00
PST - ppublish
SO - Acupunct Med. 2008 Mar;26(1):51-6.

PMID- 17954385
OWN - NLM
STAT- MEDLINE
DA - 20071023
DCOM- 20080201
IS - 1475-4916 (Print)
IS - 1475-4916 (Linking)
VI - 96
IP - 4
DP - 2007 Oct
TI - Atrial paroxysmal tachycardia in dogs and its management with homeopathic
Digitalis--two case reports.
PG - 270-2
AB - Homeopathic Digitalis 6c was evaluated in two clinical cases of atrial paroxysmal
tachycardia in dogs. Tachycardias are common cardiac problems in dogs, and atrial
paroxysmal tachycardia is a serious cardiac arrhythmia that may lead to syncope.
Both adult dogs (Labrador and German Shepherd) were treated with Digitalis 6c, 4
drops orally four times daily for 7 days. Following treatment with Digitalis 6c
heart rate stabilised and synchronized atrial and ventricular electrical activity
was restored in 7 days.
FAU - Varshney, J P
AU - Varshney JP
AD - Division of Medicine, Indian Veterinary Research Institute, Izatnagar 243 122,
India. jpvarshney@gmail.com
FAU - Chaudhuri, S
AU - Chaudhuri S
LA - eng
PT - Case Reports
PT - Journal Article
PL - Scotland
TA - Homeopathy
JT - Homeopathy : the journal of the Faculty of Homeopathy
JID - 101140517
RN - 0 (Anticonvulsants)
RN - 0 (Plant Extracts)
SB - IM
MH - Animals
MH - Anticonvulsants/therapeutic use
MH - Atrial Fibrillation/therapy/*veterinary
MH - *Atropa belladonna
MH - Dog Diseases/*drug therapy
MH - Dogs
MH - Female
MH - Homeopathy/*methods
MH - Male
MH - Phytotherapy
MH - Plant Extracts/therapeutic use
MH - Research Design
MH - Tachycardia, Paroxysmal/drug therapy/*veterinary
MH - Treatment Outcome
EDAT- 2007/10/24 09:00
MHDA- 2008/02/02 09:00
CRDT- 2007/10/24 09:00
PHST- 2007/01/17 [received]
PHST- 2007/08/20 [revised]
PHST- 2007/08/20 [accepted]
AID - S1475-4916(07)00106-3 [pii]
AID - 10.1016/j.homp.2007.08.017 [doi]
PST - ppublish
SO - Homeopathy. 2007 Oct;96(4):270-2.

PMID- 17393628
OWN - NLM
STAT- MEDLINE
DA - 20070330
DCOM- 20090428
LR - 20101103
IS - 0255-2922 (Print)
IS - 0255-2922 (Linking)
VI - 27
IP - 1
DP - 2007 Mar
TI - The TCM stage-oriented treatment for chronic cardiac insufficiency.
PG - 49-54
AB - Generally, heart failure at the stable stage can be treated mainly with TCM
drugs. Cardiac insufficiency of degree I and II can be simply treated with
Chinese drugs. However, the western medicine ACEI is suggested to be used at the
same time. For heart failure of degree III, measures of the western medical
treatment should be adopted accordingly, such as the use of diuretics or Digoxin
to control atrial fibrillation; beta-receptor blockers to increase the density of
beta-receptor on the depleted myocardial cell membrane, so as to increase the
sensitivity of the myocardial cells to CA, and effectively prevent the fatal
ventricular fibrillation. At the acute aggravation stage of cardiac
insufficiency, the inducing factors should be first eliminated to control the
condition as soon as possible; and at the critical moment, modern medicine should
be used. In case of acute pulmonary edema, emergency treatment should be given to
save the patient's life. When the acute pulmonary edema is alleviated, Chinese
drugs can be used, based on the TCM syndrome differentiation, mainly for removing
the pathogenic fluid retention, and restoring the heart-qi and heart-yang.
FAU - Jiang, Meixian
AU - Jiang M
AD - Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese
Medicine, Shanghai 200021, China.
LA - eng
PT - Journal Article
PT - Research Support, Non-U.S. Gov't
PL - China
TA - J Tradit Chin Med
JT - Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan /
sponsored by All-China Association of Traditional Chinese Medicine, Academy of
Traditional Chinese Medicine
JID - 8211546
RN - 0 (Cardiotonic Agents)
RN - 0 (Diuretics)
RN - 0 (Drugs, Chinese Herbal)
SB - IM
MH - Cardiotonic Agents/therapeutic use
MH - Chronic Disease/therapy
MH - Diuretics/therapeutic use
MH - Drug Therapy, Combination
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Heart Failure/*drug therapy/pathology
MH - Humans
MH - *Medicine, Chinese Traditional
EDAT- 2007/03/31 09:00
MHDA- 2009/04/29 09:00
CRDT- 2007/03/31 09:00
PST - ppublish
SO - J Tradit Chin Med. 2007 Mar;27(1):49-54.

PMID- 17370488
OWN - NLM
STAT- MEDLINE
DA - 20070320
DCOM- 20070417
LR - 20131121
IS - 0255-2930 (Print)
IS - 0255-2930 (Linking)
VI - 27
IP - 2
DP - 2007 Feb
TI - [Comparison between therapeutic effects of acupuncture and intravenous injection
of amiodarone in the treatment of paroxymal atrial fibrillation and atrial
flutter].
PG - 96-8
AB - OBJECTIVE: To probe the feasibility of acupuncture in conversion of paroxymal
atrial fibrillation and atrial flutter. METHODS: Eighty cases of atrial
fibrillation and atrial flutter were randomly divided into 2 groups, a treatment
group and a control group, 40 cases in each group. The treatment group were
treated with acupuncture at Neiguan (PC 6), Shenmen (HT 7), Danzhong (CV 17) and
others, and the control group with intravenous injection of amiodarone. The
cardiac rhythms and side effects were observed in the two groups. RESULTS: The
total effective rate of 85.0% in the treatment group was better than 67.5% in the
control group (P < 0.01). The average conversion time was (39.6 +/- 13.7) min in
the treatment group and (50.1 +/- 14.8) min in the control group with a
significant difference between the two groups (P < 0.01). No adverse effect was
found in the treatment group. CONCLUSION: Acupuncture is a safe and effective
therapy for conversion of paroxymal atrial fibrillation and atrial flutter.
FAU - Xu, Hong-Ke
AU - Xu HK
AD - Liaocheng Hospital of TCM, Shandong 252000, China. zcl@lcu.edu.cn
FAU - Zhang, Yue-Feng
AU - Zhang YF
LA - chi
PT - Comparative Study
PT - English Abstract
PT - Journal Article
PT - Randomized Controlled Trial
PL - China
TA - Zhongguo Zhen Jiu
JT - Zhongguo zhen jiu = Chinese acupuncture & moxibustion
JID - 8600658
RN - 0 (Anti-Arrhythmia Agents)
RN - N3RQ532IUT (Amiodarone)
SB - IM
MH - *Acupuncture Therapy
MH - Aged
MH - Amiodarone/administration & dosage/*therapeutic use
MH - Anti-Arrhythmia Agents/*therapeutic use
MH - Atrial Fibrillation/*therapy
MH - Atrial Flutter/*therapy
MH - Female
MH - Humans
MH - Injections, Intravenous
MH - Male
MH - Middle Aged
EDAT- 2007/03/21 09:00
MHDA- 2007/04/18 09:00
CRDT- 2007/03/21 09:00
PST - ppublish
SO - Zhongguo Zhen Jiu. 2007 Feb;27(2):96-8.

PMID- 16983923
OWN - NLM
STAT- MEDLINE
DA - 20060920
DCOM- 20080102
LR - 20131121
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 26
IP - 7
DP - 2006 Jul
TI - [Effect of combination of Chinese and Western medicines on sinus rhythm
maintenance in patients with auricular fibrillation after conversion].
PG - 644-6
AB - OBJECTIVE: To investigate the curative effects of irbesartan, amiodarone and
Wenxin Granule (WG), applied alone or in combination, on sinus rhythm maintenance
in patients with auricular fibrillation (AF) after conversion. METHODS: Forty-one
patients of persistent AF, after their fibrillation being converted, were divided
into three groups randomly, and treated with amiodarone (group A, n=14),
irbesartan and amiodarone (group B, n=15), and WG plus irbesartan and amiodarone
(group C, n=12) respectively for 6 months. RESULTS: Compared with that before
treatment, the inner diameter of atria sinistrum reduced in group B and C, and
the reduction in the latter was superior to that in the former (P < 0.05); the
diameter of left ventricle also reduced in group C (P < 0.05); and the
maintenance rate of sinus rhythm was higher in group C than that in group A (P <
0.05). CONCLUSION: Combined therapy of Chinese and Western medicines shows
synergistic effect of anti-arrhythmia.
FAU - Xie, Pei-yi
AU - Xie PY
AD - Department of Cardiology, Tongde Hospital, Hangzhou. xiepiyi@163.com
FAU - Shen, Sheng-hui
AU - Shen SH
LA - chi
PT - English Abstract
PT - Journal Article
PT - Randomized Controlled Trial
PL - China
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Biphenyl Compounds)
RN - 0 (Drugs, Chinese Herbal)
RN - 0 (Tetrazoles)
RN - 138402-11-6 (irbesartan)
RN - N3RQ532IUT (Amiodarone)
SB - IM
MH - Aged
MH - Amiodarone/therapeutic use
MH - Anti-Arrhythmia Agents/*therapeutic use
MH - Atrial Fibrillation/*drug therapy
MH - Biphenyl Compounds/therapeutic use
MH - Drug Therapy, Combination
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Female
MH - Humans
MH - Male
MH - Middle Aged
MH - *Phytotherapy
MH - Tetrazoles/therapeutic use
EDAT- 2006/09/21 09:00
MHDA- 2008/01/03 09:00
CRDT- 2006/09/21 09:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 Jul;26(7):644-6.

PMID- 16949949
OWN - NLM
STAT- MEDLINE
DA - 20060904
DCOM- 20061003
LR - 20071115
IS - 1532-6586 (Electronic)
IS - 0161-4754 (Linking)
VI - 29
IP - 7
DP - 2006 Sep
TI - Spinal epidural hematoma after spinal manipulative therapy in a patient
undergoing anticoagulant therapy: a case report.
PG - 582-5
AB - OBJECTIVE: We report on the case of a patient with spinal epidural hematoma (SEH)
after spinal manipulative therapy and review features of reported cases of a
similar nature. CLINICAL FEATURES: The patient was undergoing Coumadin
anticoagulant therapy for atrial fibrillation and presented to the chiropractor
complaining of a stiff neck. After cervical manipulation, he developed
paresthesia in both feet, progressing to motor deficits in all 4 extremities. He
required a laminectomy and evacuation of a clot indenting the spinal cord.
RESULTS: Review of the literature revealed 7 reported cases of SEH after
manipulation; 5 patients underwent cervical manipulation and 1 patient received
Coumadin therapy. CONCLUSION: Practitioners of spinal manipulative therapy should
be aware of SEH as a possible complication of manipulation in patients at risk
and should exercise caution in the care of patients undergoing anticoagulant
therapy.
FAU - Whedon, James M
AU - Whedon JM
AD - Trauma Program, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756, USA.
james.m.whedon@hitchcock.org
FAU - Quebada, Patricia B
AU - Quebada PB
FAU - Roberts, David W
AU - Roberts DW
FAU - Radwan, Tarek A
AU - Radwan TA
LA - eng
PT - Case Reports
PT - Journal Article
PT - Review
PL - United States
TA - J Manipulative Physiol Ther
JT - Journal of manipulative and physiological therapeutics
JID - 7807107
RN - 0 (Anticoagulants)
SB - IM
MH - Aged
MH - Anticoagulants/*adverse effects
MH - Atrial Fibrillation/drug therapy
MH - Heart Failure/drug therapy
MH - Hematoma, Epidural, Spinal/diagnosis/*etiology/surgery
MH - Humans
MH - Male
MH - Manipulation, Chiropractic/*adverse effects
RF - 24
EDAT- 2006/09/05 09:00
MHDA- 2006/10/04 09:00
CRDT- 2006/09/05 09:00
PHST- 2005/10/01 [received]
PHST- 2005/11/08 [revised]
PHST- 2005/11/13 [accepted]
AID - S0161-4754(06)00180-1 [pii]
AID - 10.1016/j.jmpt.2006.06.017 [doi]
PST - ppublish
SO - J Manipulative Physiol Ther. 2006 Sep;29(7):582-5.

PMID- 16883915
OWN - NLM
STAT- MEDLINE
DA - 20060803
DCOM- 20071228
LR - 20131121
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 26
IP - 5
DP - 2006 May
TI - [Clinical observation on effect and safety of combined use of wenxin granule and
amiodarone for conversion of auricular fibrillation].
PG - 445-8
AB - OBJECTIVE: To observe the clinical effect of the combined use of amiodarone and
Wenxin Granule (WXG) in auricular fibrillation (AF) conversion and its safety.
METHODS: Two hundred and twenty-four patients, in whom AF lasted for less than 1
year, were enrolled and randomly assigned into two groups, 112 in each group.
Patients in the treated group were treated with WXG and amiodorane and the others
in the control group were orally administered with amiodarone alone. The
accumulative conversion rate of AF and adverse reaction were monitored during the
6-month observation period. RESULTS: Six-month observation was completed in 109
cases in the treated group and 107 in the control group, while 3 cases and 5
cases in the two groups were dropped out respectively. The difference of
accumulative AF conversion rates between the two groups become significant early
after one month medication (P < 0.05), and was 65.1% and 47.7% respectively after
6-month of treatment (P < 0.05). Inter-group significant difference was also
shown in the aspects of average conversion time, dosage of amiodarone required
and the occurrence of adverse reaction (P < 0.05). CONCLUSION: Combined use of
WXG and amiodarone has a better effect in improving conversion rate of AF,
shortening conversion time and decreasing the required dosage of amiodarone in
treating AF as compared with the treatment with amiodarone alone, and by which
the adverse reaction of long-term using amiodarone could be avoided.
FAU - Wang, Min
AU - Wang M
AD - Department of Cardiology, Zhejiang Provincial Hospital of Integrative Traditional
Chinese and Western Medicine, Hangzhou. wangmindoctor@sina.com
FAU - Yu, Yi-bo
AU - Yu YB
FAU - Huang, Shi-en
AU - Huang SE
LA - chi
PT - English Abstract
PT - Journal Article
PT - Randomized Controlled Trial
PL - China
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Drugs, Chinese Herbal)
RN - N3RQ532IUT (Amiodarone)
SB - IM
MH - Aged
MH - Amiodarone/adverse effects/*therapeutic use
MH - Anti-Arrhythmia Agents/therapeutic use
MH - Atrial Fibrillation/*drug therapy
MH - Drug Therapy, Combination
MH - Drugs, Chinese Herbal/*therapeutic use
MH - Female
MH - Humans
MH - Male
MH - Middle Aged
MH - *Phytotherapy
MH - Safety
EDAT- 2006/08/04 09:00
MHDA- 2007/12/29 09:00
CRDT- 2006/08/04 09:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006 May;26(5):445-8.

PMID- 16409967
OWN - NLM
STAT- MEDLINE
DA - 20060113
DCOM- 20060801
LR - 20121115
IS - 1672-1977 (Print)
IS - 1672-1977 (Linking)
VI - 4
IP - 1
DP - 2006 Jan
TI - [Effects of tetramethylpyrazine on fibrosis of atrial tissue and atrial
fibrillation in a canine model of congestive heart failure induced by ventricular
tachypacing].
PG - 35-8
AB - OBJECTIVE: To explore the effects of tetramethylpyrazine (TMP) on fibrosis of
atrial tissue and atrial fibrillation in a canine model of congestive heart
failure (CHF) induced by ventricular tachypacing. METHODS: Twenty-one healthy
mongrel dogs were randomly divided into three groups, which were normal control
group, untreated group and TMP-treated group. Atrial fibrillation (AF) was
induced by burst of atrial pacing, after the canine model of CHF was established.
The atrial tissues were sampled and stained with Mallory's trichromic stains,
then the fibrosis in the atrial tissues was analyzed. The left ventricular
ejection fraction (LVEF) was evaluated by echocardiography. The levels of
angiotensin II (AngII), aldosterone (ALD), amino-terminal peptide of type III
procollagen (PIIINP)ilaminin (LN) and hyaluronic acid (HA) in peripheral blood
were examined by radioimmunoassay. RESULTS: The LVEF was significantly decreased
in the untreated group as compared with that in the normal control group
(P<0.01), while the frequencies of AF and sustaining AF were significantly
increased and the AF duration was obviously prolonged in the untreated group as
compared with those in the normal control group (P<0.01). The fibrosis degree in
the left or right atrial tissue in the untreated group was more serious than that
in the normal control group (P<0.01). The AF duration was positively correlated
with the fibrosis degree in the left atrial tissue (r=0.84, P=0.018). The levels
of AngII, ALD, PIIINP and HA in peripheral blood were significantly higher in the
untreated group than those in the normal control group (P<0.05 or P<0.01). The
level of AngII was positively correlated with the level of ALD in peripheral
blood (r=0.759, P=0.048). The LVEF and the frequency of sustaining AF were both
significantly improved in the TMP-treated group as compared with those in the
untreated group (P<0.05). The fibrosis in the left or right atrial tissue in the
untreated group was more serious than that in the untreated group (P<0.01). The
levels of AngII and PIIINP in peripheral blood were also markedly higher in the
TMP-treated group than those in the untreated group (P=0.05, P=0.01). CONCLUSION:
Tetramethylpyrazine has the effect of reducing the fibrosis degree of atrial
tissue in dogs with CHF, and this efficacy may be related to the mechanism of
decreasing the frequency of AF and shortening the AF duration.
FAU - Lin, Ya-Zhou
AU - Lin YZ
AD - Department of Cardiology, Fujian Provincial Research Institute for Cardiovascular
Diseases, Fujian Provincial Hospital, Fuzhou, Fujian Province 350001, China.
asialin@sina.com
FAU - Xu, Chun-Xuan
AU - Xu CX
FAU - Deng, Yu-Lian
AU - Deng YL
FAU - Chen, Lin
AU - Chen L
FAU - Huang, Hai
AU - Huang H
FAU - Du, Jian
AU - Du J
LA - chi
PT - English Abstract
PT - Journal Article
PL - China
TA - Zhong Xi Yi Jie He Xue Bao
JT - Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
JID - 101199657
RN - 0 (Pyrazines)
RN - V80F4IA5XG (tetramethylpyrazine)
SB - IM
MH - Animals
MH - Atrial Fibrillation/complications/*drug therapy
MH - Cardiac Pacing, Artificial
MH - Dogs
MH - Female
MH - Fibrosis/prevention & control
MH - Heart Atria/*pathology
MH - Heart Failure/complications/*drug therapy
MH - Male
MH - Pyrazines/pharmacology/*therapeutic use
MH - Random Allocation
EDAT- 2006/01/18 09:00
MHDA- 2006/08/02 09:00
CRDT- 2006/01/18 09:00
AID - 475 [pii]
PST - ppublish
SO - Zhong Xi Yi Jie He Xue Bao. 2006 Jan;4(1):35-8.

PMID- 16248254
OWN - NLM
STAT- MEDLINE
DA - 20051026
DCOM- 20071218
LR - 20121115
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 25
IP - 9
DP - 2005 Sep
TI - [Occurrence and prevention of adverse reaction induced by puerarin injection].
PG - 852-5
AB - In this paper, literature about adverse reaction induced by Puerarin injection
published in recent years were reviewed and analyzed. It was reported that
Puerarin injection can not only induce adverse reactions on multiple systems,
such as immune, blood, urinary, digestive and cardiovascular system, but so far
as to cause death. Therefore, it should be administered rationally and strictly
according to the direction and the course of medication should be rigorously
monitored to prevent the occurrence of adverse reactions.
FAU - Liu, Shao-de
AU - Liu SD
AD - Department of Pharmaceutics, Liugang Hospital of Liuzhou City, Guangxi.
Lieon7.0@163.com
FAU - Mo, Hui-ping
AU - Mo HP
LA - chi
PT - Case Reports
PT - English Abstract
PT - Journal Article
PL - China
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
RN - 0 (Isoflavones)
RN - 0 (Vasodilator Agents)
RN - Z9W8997416 (puerarin)
SB - IM
MH - Aged
MH - Anaphylaxis/*chemically induced/prevention & control
MH - Anemia, Hemolytic/*chemically induced/prevention & control
MH - Atrial Fibrillation/*chemically induced/prevention & control
MH - Female
MH - Humans
MH - Injections, Intravenous
MH - Isoflavones/*adverse effects
MH - Male
MH - Middle Aged
MH - Vasodilator Agents/adverse effects
EDAT- 2005/10/27 09:00
MHDA- 2007/12/19 09:00
CRDT- 2005/10/27 09:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Sep;25(9):852-5.

PMID- 8111194
OWN - NLM
STAT- MEDLINE
DA - 19940330
DCOM- 19940330
LR - 20151119
IS - 1003-5370 (Print)
IS - 1003-5370 (Linking)
VI - 13
IP - 8
DP - 1993 Aug
TI - [Rotundium in the treatment of atrial fibrillation].
PG - 455-7, 451
AB - L-tetrahydropalmatine (Rotundium) is an alkaloid of Corydalis turtschaninovii.
Some animal experiments had demonstrated that Rotundium had a good antiarrhythmic
effect in blocking the calcium channel and that it was a class IV antiarrhythmic
agent, similar to that of Bepridil in literatures. This is a clinical report of
Rotundium (oral given) on an atrial fibrillation (AF) patients. The therapeutical
results were evaluated by 24 hours ambulatory electrocardiographic monitoring and
ECG. The results showed that the effective rate of Rotundium on paroxysmal atrial
fibrillation and sustained atrial fibrillation of 45 mm (left atrium diameter) or
more was 30%, while LAD of less than 45 mm was 80% (P < 0.01). Among 8 cases'
duration of AF were 6 months or more, 3 cases were effective, the effective rate
37.5%, while among 10 cases' duration of AF were less than 3 weeks, 3 cases were
converted to sinus rhythm, 5 cases were effective. There was a significant
difference between two groups. Age and sex exerted no effect on efficacy. During
taking Rotundium, blood pressure had no apparent changes and no severe side
effects were found. The results showed that Rotundium is an effective, safe new
drug to treat AF, especially in paroxysmal atrial fibrillation. The
antiarrhythmic mechanism of Rotundium might be related to its prolonging of the
effective refractory period of atrial and atrioventricular node.
FAU - Wang, D J
AU - Wang DJ
AD - Inst. of Cardiovascular diseases, Tongji Medical University, Wuhan.
FAU - Mao, H Y
AU - Mao HY
FAU - Lei, M
AU - Lei M
LA - chi
PT - English Abstract
PT - Journal Article
PL - CHINA
TA - Zhongguo Zhong Xi Yi Jie He Za Zhi
JT - Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese
journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie
he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban
JID - 9211576
RN - 0 (Anti-Arrhythmia Agents)
RN - 0 (Berberine Alkaloids)
RN - 0 (Calcium Channel Blockers)
RN - 0 (Drugs, Chinese Herbal)
RN - 3X69CO5I79 (tetrahydropalmatine)
SB - IM
MH - Adult
MH - Aged
MH - Anti-Arrhythmia Agents/*therapeutic use
MH - Atrial Fibrillation/*drug therapy
MH - Berberine Alkaloids/*therapeutic use
MH - Calcium Channel Blockers/therapeutic use
MH - Drugs, Chinese Herbal/therapeutic use
MH - Electrocardiography, Ambulatory
MH - Female
MH - Humans
MH - Male
MH - Middle Aged
EDAT- 1993/08/01
MHDA- 1993/08/01 00:01
CRDT- 1993/08/01 00:00
PST - ppublish
SO - Zhongguo Zhong Xi Yi Jie He Za Zhi. 1993 Aug;13(8):455-7, 451.

Download All Files (To download individual files, select them in the “Files” panel above)

Best for data sets < 3 GB. Downloads all files plus metadata into a zip file.



Best for data sets > 3 GB. Globus is the platform Deep Blue Data uses to make large data sets available.   More about Globus